This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

May 10–14, 2021
Shanghai and DigitalHybrid Event

Trency Gu, PhD
Managing Director at Sequoia Capital


Trency Gu, Managing Director at Sequoia China, focusing on healthcare investment, esp. on innovative therapeutics, molecular diagnostics and precision medicine. Prior to joining Sequoia in 2012, she worked as an Associate at OrbiMed Asia team, focusing on healthcare investment, including pharma, biotech and medical devices. Prior to joining OrbiMed, Dr. Gu worked as a Project Manager at Eli Lilly Global External Research and Development Department in Shanghai, where she was involved in the collaborations and partnering activities. Prior, she was a Director for Development Planning at Shanghai Genomics, a biotech company focused on drug discovery and development. There, she managed in-licensing activities and IND-enabling studies for NCE development. Dr. Gu has a B.S. with double majors in Biotechnology and English, and a Ph.D. in Biochemistry and Molecular Biology, both from Shanghai Jiao Tong University.

Agenda Sessions

  • Partnering Bootcamp LIVE - Session 2: The Investors’ Perspectives and Advice on Healthcare IPOs